Welcome!

News Feed Item

Renal Pain Global Clinical Trials Review, H2, 2014

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Renal Pain Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/703965/Renal-Pain-Global-Clinical-Trials-Review-H2-2014.html

Renal Pain Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Renal Pain Global Clinical Trials Review, H2, 2014" provides data on the Renal Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Renal Pain 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Renal Pain to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Renal Pain to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Renal Pain 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Renal Pain Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Pfizer Inc. 30
Clinical Trial Overview of Pfizer Inc. 30
Emcure Pharmaceuticals Ltd. 31
Clinical Trial Overview of Emcure Pharmaceuticals Ltd. 31
Clinical Trial Overview of Top Institutes / Government 32
Tehran University of Medical Sciences 32
Clinical Trial Overview of Tehran University of Medical Sciences 32
Seoul National University Hospital 33
Clinical Trial Overview of Seoul National University Hospital 33
University of Minnesota 34
Clinical Trial Overview of University of Minnesota 34
The International Kidney Stone Institute 35
Clinical Trial Overview of The International Kidney Stone Institute 35
Yale University 36
Clinical Trial Overview of Yale University 36
Ahvaz Jundishapur University of Medical Sciences 37
Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 37
Isfahan University of Medical Sciences 38
Clinical Trial Overview of Isfahan University of Medical Sciences 38
Department of Health, UK 39
Clinical Trial Overview of Department of Health, UK 39
University of Monastir 40
Clinical Trial Overview of University of Monastir 40
Korea Institute of Oriental Medicine 41
Clinical Trial Overview of Korea Institute of Oriental Medicine 41
Five Key Clinical Profiles 42
Appendix 62
Abbreviations 62
Definitions 62
Research Methodology 63
Secondary Research 63
About GlobalData 64
Contact Us 64
Disclaimer 64
Source 64

List of Tables

Renal Pain Therapeutics, Global, Clinical Trials by Region, 2014* 7
Renal Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Renal Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Renal Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Renal Pain Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Renal Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Renal Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Renal Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Renal Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Renal Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Renal Pain Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Renal Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Renal Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Renal Pain Therapeutics, Global, Suspended Clinical Trials, 2014* 24
Renal Pain Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Renal Pain Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Renal Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Renal Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Renal Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Renal Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Renal Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 30
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Emcure Pharmaceuticals Ltd., 2014* 31
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 32
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 33
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 34
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by The International Kidney Stone Institute, 2014* 35
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 36
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2014* 37
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2014* 38
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2014* 39
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Monastir, 2014* 40
Renal Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea Institute of Oriental Medicine, 2014* 41

List of Figures

Renal Pain Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Renal Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Renal Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Renal Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Renal Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Renal Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Renal Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Renal Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Renal Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Renal Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Renal Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Renal Pain Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Renal Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Renal Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Renal Pain Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Renal Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Renal Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Renal Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Renal Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Renal Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 63


Read the full report:
Renal Pain Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/703965/Renal-Pain-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
DXWorldEXPO | CloudEXPO are the world's most influential, independent events where Cloud Computing was coined and where technology buyers and vendors meet to experience and discuss the big picture of Digital Transformation and all of the strategies, tactics, and tools they need to realize their goals. Sponsors of DXWorldEXPO | CloudEXPO benefit from unmatched branding, profile building and lead generation opportunities.
Daniel Jones is CTO of EngineerBetter, helping enterprises deliver value faster. Previously he was an IT consultant, indie video games developer, head of web development in the finance sector, and an award-winning martial artist. Continuous Delivery makes it possible to exploit findings of cognitive psychology and neuroscience to increase the productivity and happiness of our teams.
Digital transformation has increased the pace of business creating a productivity divide between the technology haves and have nots. Managing financial information on spreadsheets and piecing together insight from numerous disconnected systems is no longer an option. Rapid market changes and aggressive competition are motivating business leaders to reevaluate legacy technology investments in search of modern technologies to achieve greater agility, reduced costs and organizational efficiencies. ...
Disruption, Innovation, Artificial Intelligence and Machine Learning, Leadership and Management hear these words all day every day... lofty goals but how do we make it real? Add to that, that simply put, people don't like change. But what if we could implement and utilize these enterprise tools in a fast and "Non-Disruptive" way, enabling us to glean insights about our business, identify and reduce exposure, risk and liability, and secure business continuity?
"We host and fully manage cloud data services, whether we store, the data, move the data, or run analytics on the data," stated Kamal Shannak, Senior Development Manager, Cloud Data Services, IBM, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
DXWorldEXPO LLC announced today that Telecom Reseller has been named "Media Sponsor" of CloudEXPO | DXWorldEXPO 2018 New York, which will take place on November 11-13, 2018 in New York City, NY. Telecom Reseller reports on Unified Communications, UCaaS, BPaaS for enterprise and SMBs. They report extensively on both customer premises based solutions such as IP-PBX as well as cloud based and hosted platforms.
Enterprises are striving to become digital businesses for differentiated innovation and customer-centricity. Traditionally, they focused on digitizing processes and paper workflow. To be a disruptor and compete against new players, they need to gain insight into business data and innovate at scale. Cloud and cognitive technologies can help them leverage hidden data in SAP/ERP systems to fuel their businesses to accelerate digital transformation success.
Enterprise architects are increasingly adopting multi-cloud strategies as they seek to utilize existing data center assets, leverage the advantages of cloud computing and avoid cloud vendor lock-in. This requires a globally aware traffic management strategy that can monitor infrastructure health across data centers and end-user experience globally, while responding to control changes and system specification at the speed of today’s DevOps teams. In his session at 20th Cloud Expo, Josh Gray, Chie...
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...
Transformation Abstract Encryption and privacy in the cloud is a daunting yet essential task for both security practitioners and application developers, especially as applications continue moving to the cloud at an exponential rate. What are some best practices and processes for enterprises to follow that balance both security and ease of use requirements? What technologies are available to empower enterprises with code, data and key protection from cloud providers, system administrators, inside...
"Calligo is a cloud service provider with data privacy at the heart of what we do. We are a typical Infrastructure as a Service cloud provider but it's been designed around data privacy," explained Julian Box, CEO and co-founder of Calligo, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
We are seeing a major migration of enterprises applications to the cloud. As cloud and business use of real time applications accelerate, legacy networks are no longer able to architecturally support cloud adoption and deliver the performance and security required by highly distributed enterprises. These outdated solutions have become more costly and complicated to implement, install, manage, and maintain.SD-WAN offers unlimited capabilities for accessing the benefits of the cloud and Internet. ...
Discussions of cloud computing have evolved in recent years from a focus on specific types of cloud, to a world of hybrid cloud, and to a world dominated by the APIs that make today's multi-cloud environments and hybrid clouds possible. In this Power Panel at 17th Cloud Expo, moderated by Conference Chair Roger Strukhoff, panelists addressed the importance of customers being able to use the specific technologies they need, through environments and ecosystems that expose their APIs to make true ...
Containers and Kubernetes allow for code portability across on-premise VMs, bare metal, or multiple cloud provider environments. Yet, despite this portability promise, developers may include configuration and application definitions that constrain or even eliminate application portability. In this session we'll describe best practices for "configuration as code" in a Kubernetes environment. We will demonstrate how a properly constructed containerized app can be deployed to both Amazon and Azure ...
Business professionals no longer wonder if they'll migrate to the cloud; it's now a matter of when. The cloud environment has proved to be a major force in transitioning to an agile business model that enables quick decisions and fast implementation that solidify customer relationships. And when the cloud is combined with the power of cognitive computing, it drives innovation and transformation that achieves astounding competitive advantage.